Further processing options
An Open-Label Dose Escalation Study to Evaluate the Safety of Administration of Nonviral Stromal Cell-Derived Factor-1 Plasmid to Treat Symptomatic Ischemic Heart Failure
Saved in:
Journal Title: | Circulation Research |
---|---|
Authors and Corporations: | , , , , , , , , , |
In: | Circulation Research, 112, 2013, 5, p. 816-825 |
Type of Resource: | E-Article |
Language: | English |
published: |
Ovid Technologies (Wolters Kluwer Health)
|
Subjects: |